Andreani, A. et al., “Nonsteroidal Antiinflammatory Agents. 2. Synthesis and Biological Activity of 2—Chlorindolecarboxylic Acids”; Journal of Medicinal Chemistry, vol. 20, No. 10, 1977, pp. 1344-1346. |
Julia, Marc, et al., “No. 208—Recherches en serie indolique. XIII. Sur quelques methoxy—5 et. —6 tryptamines”, Bulletin de La Societe Chimique de France, Paris, France; 1965, pp. 1411-1417. |
Chemical Abstracts, vol. 1/2. No. 24, Abstract No. 223181s; “Kinetis of hydrolysis of indomethacin and indomethacin ester predrigs in aqueous solution” Jun. 11, 1990, p. 407. |
Chemical Abstracts Service, “Registry Handbook”, Number Section, Registry Numbers (see, CAS RN 6264-33-1) 1965-1971, Publ. American Chemical Society. |
Von K. H. Boltze; O. Brendler, et.al., “Chemische Struktur und antiphlogistische Wirkung in der Reihe der substituierten Indol-3-essigsauren”, Arznermittel Forschung Drug Research, vol. 30 (II), No. 8A, 1980, Aulendorf, DE, pp. 1314-1325. |
Kramer, Ruther et al., “Structure and Properties of a Human Non-Pancreatic Phospholipase A2”, The Journal of Biological Chemistry, 264.10, Apr. 5, 1989, pp. 5768-5775. |
Seilhamer, Jeffery, et al., “Cloning and Recombinant Expression of Phospholipase A2 present in Pheumatoid Arthritic Synovial Fluid”; The Journal of Biological Chemistry, 254:10, Apr. 5, 1989, pp. 5335-5338. |
Kreft, A; Nelson, J. et al, “Structure-activity relationships leading to WAY-121,520, a tris aryl type. Nidomethacin-based phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor”, Issue vol. 39 (1993), pp. C33-C35, ISSN 0065-4299; publ. by Birkhauser Verlag, Basel Switzerland; (Proceedings of the Sixth International Research Assoc., Sep. 20-24, 1992 at White Haven, PA/USA, Ed., D.W. Morgan and A.K. Welton. |
Cingolani, GM, et al., “Idolizine derivatives with biological activity VI 1-(2-aminoethyl)-3-benzl-7-methoxy-2-methylindolizine, benanser in structural analogue”, Eur. J. Med. Chem. (1990) 25, pp. 709-712. |